Kidney Dialysis News
-
German stocks dropped from a six- month high, snapping two days of gains for the benchmark DAX Index, after Greece’s bailout failed to ease concern that the nation’s debt crisis will be solved.
-
Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, sold $1.5 billion of speculative-grade debt in a boosted offering as yields on such securities drop to a five-month low.
-
India’s diabetes epidemic has triggered surging demand for dialysis as the disease destroys many sufferers’ kidneys, leaving them with only months to live without treatment.
-
Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, cut its full-year revenue forecast after the debt crisis in Europe caused the euro to weaken against the U.S. dollar.
-
The German economy probably contracted in the final quarter of 2011 as the sovereign debt crisis damped demand for exports.
-
Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, said third-quarter operating profit increased as it boosted volume and improved cost management to offset lower prices in the U.S.
-
Amgen Inc. ’s anemia treatment Aranesp is safe for use in kidney patients whose disease doesn’t require dialysis, a U.S. panel found.
-
Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, aims to do more acquisitions next year and increase volume to offset lower government reimbursements in the U.S.
-
Reynolds Group Holdings Ltd., the packaging company owned by New Zealand billionaire Graeme Hart , is marketing $3 billion of debt as sales of the highest-ranking junk bonds surge.
-
DeMaurice Smith, the executive director of the National Football League players union, speaking in an interview on Bloomberg Television’s “Political Capital With Al Hunt” airing this weekend, said a player lockout next season is a “near certainty” and it would cost the U.S. economy an estimated $5 billion in lost wages, taxes and other revenue if the entire season is canceled.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page